We implemented a double-blind between-subject design where 20 healthy female volunteers received a single dose of the selective serotonin reuptake inhibitor ( SSRI ) citalopram ( 220 mg ) , while 20 control subjects ( matched on age , intelligence , and years of education ) received a placebo .